Beyond Fragmentation: Inotiv’s Unified Tox Network Accelerates Discovery
Beyond Fragmentation: How Inotiv’s Unified Toxicology Network Accelerates Drug Development
Enhancing Health Monitoring with Sentinel Free Filter Testing (SiFT)
A healthy rodent colony is vital to the scientific integrity of research results, emphasizing the importance of monitoring colonies for pathogens. However, reliably detecting pathogens can be...
The expanding reach of GLP-1 research and the role of the diet-induced obesity (DIO) model
Glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide and liraglutide, are major anti-obesity and anti-diabetes therapeutics that have produced clinically meaningful metabolic benefits. While...
Strain Selection for IMQ-Induced Psoriasis Studies
The imiquimod (IMQ)-induced psoriasis model is widely used in preclinical dermatology research due to its ability to rapidly generate localized skin inflammation that resembles key features of human...
The Role of Histopathology in Orthopedic Medical Device Assessment
The evolution and diversity of orthopedic medical devices has progressed significantly over recent years, thanks to advancements in both material innovation and technological capabilities. The...
Improving Accuracy: AI-Based Scoring and Its Impact on Cardiomyopathy Assessment
Artificial intelligence is increasingly gaining traction in pathology, offering tools for tumor detection, object identification, and tissue quantification. A recent study co-authored by Inotiv’s Dr....
Understanding ICH E14/S7B Best Practices for Nonclinical Studies
The landscape of drug development requires a comprehensive approach to ensure safety, particularly concerning cardiac function. The ICH E14/S7B guidelines represent a significant step forward in...
